Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie Regev

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 30, 2010
Gender disparity in liver transplant waiting-list mortality: the importance of kidney functionAyse L Mindikoglu, Arie Regev, Stephen L Seliger, et al.
Hepatology (Baltimore, Md.)|February 25, 2025
Assessment of liver injury potential of investigational medicines in drug developmentNaga Chalasani, Paul H Hayashi, Debra Luffer-Atlas, et al.
The American Journal of Gastroenterology|June 30, 2005
Focal nodular hyperplasia in identical twinsAyse L Mindikoglu, Arie Regev, Joe U Levi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 10, 2006
Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literatureEdgardo S Santos, Leopoldo R Arosemena, Luis E Raez, et al.
Gastrointestinal Endoscopy|October 7, 2003
Pretreatment laparoscopic appearance of the liver can predict response to combination therapy with interferon alpha 2B and ribavirin in chronic hepatitis CJasmohan S Bajaj, Enrique Molina, Arie Regev, et al.
Drug Safety|October 30, 2014
The clinical liver safety assessment best practices workshop: rationale, goals, accomplishments and the futurePaul B Watkins, Michael Merz, Mark I Avigan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 26, 2009
Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver diseaseVishal Bhagat, Ayse L Mindikoglu, Carmine G Nudo, et al.
Drug Safety|December 15, 2010
Risk of hepatic events in patients treated with vancomycin in clinical studies: a systematic review and meta-analysisYan Chen, Xiao Yan Yang, Michael Zeckel, et al.
Drug Safety|October 30, 2014
Causality assessment for suspected DILI during clinical phases of drug developmentArie Regev, Leonard B Seeff, Michael Merz, et al.
Digestive Diseases and Sciences|January 16, 2007
Imatinib mesylate (gleevec) hepatotoxicityAyse L Mindikoglu, Arie Regev, Pablo A Bejarano, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 30, 2010
Gender disparity in liver transplant waiting-list mortality: the importance of kidney functionAyse L Mindikoglu, Arie Regev, Stephen L Seliger, et al.
Hepatology (Baltimore, Md.)|February 25, 2025
Assessment of liver injury potential of investigational medicines in drug developmentNaga Chalasani, Paul H Hayashi, Debra Luffer-Atlas, et al.
The American Journal of Gastroenterology|June 30, 2005
Focal nodular hyperplasia in identical twinsAyse L Mindikoglu, Arie Regev, Joe U Levi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 10, 2006
Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literatureEdgardo S Santos, Leopoldo R Arosemena, Luis E Raez, et al.
Gastrointestinal Endoscopy|October 7, 2003
Pretreatment laparoscopic appearance of the liver can predict response to combination therapy with interferon alpha 2B and ribavirin in chronic hepatitis CJasmohan S Bajaj, Enrique Molina, Arie Regev, et al.
Drug Safety|October 30, 2014
The clinical liver safety assessment best practices workshop: rationale, goals, accomplishments and the futurePaul B Watkins, Michael Merz, Mark I Avigan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 26, 2009
Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver diseaseVishal Bhagat, Ayse L Mindikoglu, Carmine G Nudo, et al.
Drug Safety|December 15, 2010
Risk of hepatic events in patients treated with vancomycin in clinical studies: a systematic review and meta-analysisYan Chen, Xiao Yan Yang, Michael Zeckel, et al.
Drug Safety|October 30, 2014
Causality assessment for suspected DILI during clinical phases of drug developmentArie Regev, Leonard B Seeff, Michael Merz, et al.
Digestive Diseases and Sciences|January 16, 2007
Imatinib mesylate (gleevec) hepatotoxicityAyse L Mindikoglu, Arie Regev, Pablo A Bejarano, et al.
Pageof 7